相似文献
1
Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies.
J Thromb Haemost. 2011 Jul;9 Suppl 1(Suppl 1):189-94. doi: 10.1111/j.1538-7836.2011.04316.x.
2
Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.
Curr Drug Targets. 2020;21(2):193-201. doi: 10.2174/1389450120666190926152914.
3
The interplay between host haemostatic systems and spp. infections.
Crit Rev Microbiol. 2020 Mar;46(2):121-135. doi: 10.1080/1040841X.2020.1735299. Epub 2020 Mar 6.
4
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.
Front Cell Infect Microbiol. 2014 Sep 11;4:128. doi: 10.3389/fcimb.2014.00128. eCollection 2014.
5
New Pathogenesis Mechanisms and Translational Leads Identified by Multidimensional Analysis of Necrotizing Myositis in Primates.
mBio. 2020 Feb 18;11(1):e03363-19. doi: 10.1128/mBio.03363-19.
6
Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein.
J Biol Chem. 2015 Jul 24;290(30):18833-42. doi: 10.1074/jbc.M115.655365. Epub 2015 Jun 12.
7
Streptococcal toxins: role in pathogenesis and disease.
Cell Microbiol. 2015 Dec;17(12):1721-41. doi: 10.1111/cmi.12531. Epub 2015 Nov 17.
8
Group a remains viable inside fibrin clots and gains access to human plasminogen for subsequent fibrinolysis and dissemination.
Microbiol Spectr. 2025 Feb 4;13(2):e0260724. doi: 10.1128/spectrum.02607-24. Epub 2025 Jan 13.
9
[Persistence of Streptococcus pyogenes].
Zh Mikrobiol Epidemiol Immunobiol. 2009 May-Jun(3):104-9.
10
Variable region in streptococcal M-proteins provides stable binding with host fibrinogen for plasminogen-mediated bacterial invasion.
J Biol Chem. 2017 Apr 21;292(16):6775-6785. doi: 10.1074/jbc.M116.768937. Epub 2017 Mar 9.
引用本文的文献
1
Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection.
Sci Rep. 2017 Sep 18;7(1):11798. doi: 10.1038/s41598-017-11276-z.
2
Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes.
PLoS One. 2017 Jan 26;12(1):e0170936. doi: 10.1371/journal.pone.0170936. eCollection 2017.
3
Pathogen activators of plasminogen.
J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S106-14. doi: 10.1111/jth.12939.
4
Targeting the host hemostatic system function in bacterial infection for antimicrobial therapies.
J Thromb Thrombolysis. 2014 Jan;37(1):66-73. doi: 10.1007/s11239-013-0994-9.
5
A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes.
PLoS Pathog. 2013;9(8):e1003529. doi: 10.1371/journal.ppat.1003529. Epub 2013 Aug 1.
6
A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection.
PLoS Pathog. 2013;9(7):e1003469. doi: 10.1371/journal.ppat.1003469. Epub 2013 Jul 4.
7
Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation.
PLoS One. 2012;7(10):e47255. doi: 10.1371/journal.pone.0047255. Epub 2012 Oct 15.
本文引用的文献
1
Streptococcal M proteins and their role as virulence determinants.
Clin Chim Acta. 2010 Sep 6;411(17-18):1172-80. doi: 10.1016/j.cca.2010.04.032. Epub 2010 May 7.
2
The streptococcal M protein: a highly versatile molecule.
Trends Microbiol. 2010 Jun;18(6):275-82. doi: 10.1016/j.tim.2010.02.007. Epub 2010 Mar 27.
3
Contact system activation in severe infectious diseases.
J Mol Med (Berl). 2010 Feb;88(2):121-6. doi: 10.1007/s00109-009-0564-y.
4
A PROTEOLYTIC ENZYME OF SERUM: CHARACTERIZATION, ACTIVATION, AND REACTION WITH INHIBITORS.
J Gen Physiol. 1945 Jul 20;28(6):559-83. doi: 10.1085/jgp.28.6.559.
5
THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.
J Exp Med. 1933 Sep 30;58(4):485-502. doi: 10.1084/jem.58.4.485.
6
Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen.
Blood. 2009 Jul 9;114(2):444-51. doi: 10.1182/blood-2008-10-182527. Epub 2009 May 11.
7
Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP.
FASEB J. 2009 Sep;23(9):3100-12. doi: 10.1096/fj.09-131458. Epub 2009 May 5.
8
Defining the structural basis of human plasminogen binding by streptococcal surface enolase.
J Biol Chem. 2009 Jun 19;284(25):17129-17137. doi: 10.1074/jbc.M109.004317. Epub 2009 Apr 10.
9
Future antibiotics scenarios: is the tide starting to turn?
Int J Antimicrob Agents. 2009 Jul;34(1):15-20. doi: 10.1016/j.ijantimicag.2009.02.005. Epub 2009 Apr 1.
10
Reduced thrombin generation increases host susceptibility to group A streptococcal infection.
Blood. 2009 Feb 5;113(6):1358-64. doi: 10.1182/blood-2008-07-170506. Epub 2008 Dec 3.
Zotero 插件